Neuropsychopharmacology
- For those with schizophrenia, does cannabidiol make cannabis use safer?11 months ago
- Leveraging high-resolution brain imaging and (epi)genomic approaches to improve women’s mental health11 months ago
- Methylone promotes neurite outgrowth and has long-lasting effects on fear extinction learning11 months ago
- Blood and neuronal extracellular vesicle mitochondrial disruptions in schizophrenia11 months ago
- The role of the prelimbic cortex to nucleus accumbens core projection in the reinstatement of cocaine-seeking after cocaine-alcohol polysubstance use11 months ago
- Hearing and early life adversity: effects of developmental stress on sensory processing11 months ago
- Knockdown of USP22 alleviates LPS-induced microglial inflammation and mouse depressive-like behaviors via KAT2A11 months ago
Journal of Psychopharmacology
- Navigating the challenge of patient selection and scales to measure outcomes in ketamine trials for treatment-resistant depression2 years ago
- Safety, tolerability and pharmacokinetics of the phosphodiesterase 2 inhibitor BI 474121: An overview of phase I randomized trials in healthy volunteers2 years ago
- Blackcurrant (Ribes nigrum L.) improves cholinergic signaling and protects against chronic Scopolamine-induced memory impairment in mice2 years ago
- Long-read sequencing of CYP2D6 may improve psychotropic prescribing and treatment outcomes: A systematic review and meta-analysis2 years ago
- Beneficial adjunctive effects of the 5HT3 receptor antagonist ondansetron on symptoms, function and cognition in early phase schizophrenia in a double-blind, 2 × 2 factorial design, randomised controlled comparison with simvastatin2 years ago
- Is lack of goal-conflict-specific rhythmicity a biomarker for treatment resistance in generalised anxiety but not social anxiety or major depression?2 years ago
- High-dose Vitamin-B6 reduces sensory over-responsivity2 years ago
European Neuropsychopharmacology
- Deciphering the impact of metabolic anomalies in relation to severe mental illness2 years ago
- Mixed features in mood episodes: Mismatch between intensity and valence in emotional responses2 years ago
- Ketamine and new targets for treatment-resistant depression: A role for transforming growth factor-β1?2 years ago
- Minor physical anomalies in schizophrenia and first-degree relatives in comparison to healthy controls: A systematic review and meta-analysis2 years ago
- Shared vulnerability and sex-dependent polygenic burden in psychotic disorders2 years ago
- Gray matter volumetric correlates of the polygenic risk of depression: A study of the Human Connectome Project data2 years ago
- Open science in biomedicine: Overcoming barriers in omics studies2 years ago